遵循科学规律开展防控。新冠病毒是新病毒，对其认识需要有个过程。积极借鉴以往经验，紧密结合中国国情，遵循流行病学规律，探索行之有效的方法手段，用中国办法破解疫情防控难题。注重发挥病毒学、流行病学、临床医学等领域专家作用，及时开展疫情形势分析研判，提出防控策略建议，充分尊重专家意见，增强疫情防控的科学性专业性。秉持科学态度，加强病毒感染、致病机理、传播途径、传播能力等研究，与世界卫生组织及其他国家和地区保持沟通交流。随着对病毒认识的不断深化，及时调整和优化工作措施，不断提升防控水平。根据疫情形势变化和评估结果，先后制修订6版新冠肺炎防控方案，科学规范开展病例监测、流行病学调查、可疑暴露者和密切接触者管理以及实验室检测等工作。针对重点人群、重点场所、重点单位发布15项防控技术方案、6项心理疏导工作方案，并细化形成50项防控技术指南，进一步提高疫情防控的科学性精准性。

Prevention and control efforts have been based on science.Covid-19 is a new virus and it will take time for humanity to understand it completely. In its quest for victory over the coronavirus, China has been mapping its own route to success – one based on reliable experience, tailored to its national conditions, and rooted in sound epidemiological practice.

China values the role of experts in virology, epidemiology, clinical medicine and related fields. China’s response has been professional because its response measures were based on timely analyses and assessments by scientists and public health experts, whose views and proposals were fully respected.

China has given full support to factual and scientific research on virus infection, pathogenesis, transmission routes and transmissibility while maintaining exchanges and communication with the WHO and other countries and regions.

With a growing body of knowledge of the virus, China has modified and optimized its response measures in a timely manner to make them more effective. It has developed a Covid-19 prevention and control protocol and updated it five times based on assessments of the evolving epidemic dynamics. The protocol provides a set of reliable standards for case monitoring, epidemiological investigation, management of close contacts and of those suspected of exposure to infection, and procedure-based tests in laboratories. China has also published 15 technical manuals on epidemic prevention and control for key population groups, locations and organizations, 6 work plans on psychological counseling for people affected by Covid-19, and 50 specific technical guidelines. All of this has ensured that China’s prevention and control efforts are more targeted and science-based.

　　（三）全力救治患者、拯救生命

　　医疗救治始终以提高收治率和治愈率、降低感染率和病亡率的“两提高”“两降低”为目标，坚持集中患者、集中专家、集中资源、集中救治“四集中”原则，坚持中西医结合，实施分类救治、分级管理。对重症患者，调集最优秀的医生、最先进的设备、最急需的资源，不惜一切代价进行救治，大幅度降低病亡率；对轻症患者及早干预，尽可能在初期得以治愈，大幅度降低转重率。

3.An All-Out Effort to Treat Patients and Save Lives

From the outset, China’s goal in its medical response to Covid-19 has been to improve the patient admission and cure rates and reduce the infection and fatality rates. The infected were treated in dedicated medical facilities where medical specialists from all over the country and all the necessary medical resources were concentrated. Both traditional Chinese medicine and Western medicine were applied. A condition-specific and category-based approach was applied to medical treatment of patients. Severe cases were treated by the best doctors using the most advanced equipment, and critical supplies were pooled to save lives at all costs. It is through such efforts that the Covid-19 fatality rate in China has dropped sharply. Early medical intervention has made it possible to have patients with mild symptoms cured without delay, thus significantly reducing the risk that their condition might worsen.

　　集中优势资源加强重症救治。疫情突发导致武汉市医疗资源挤兑。针对疫情初期患者数量激增与床位资源不足的突出矛盾，集中资源和力量在武汉市建设扩充重症定点医院和救治床位，将全部重症危重症患者集中到综合实力最强且具备呼吸道传染性疾病收治条件的综合医院集中开展救治。建成火神山、雷神山两座各可容纳1000多张床位的传染病专科医院，改扩建一批定点医院，改造一批综合医院，使重症床位从1000张左右迅速增加至9100多张，解决了重症患者大规模收治难题。优化重症救治策略，制定个体化医疗救治方案。建立专家巡查制度，定期组织专家团队对武汉市定点医院重症患者救治进行巡诊，评估患者病情和治疗方案。针对超过80%的重症患者合并严重基础性疾病情况，实行“一人一策”，建立感染、呼吸、重症、心脏、肾脏等多学科会诊制度，并制定重症、危重症护理规范，推出高流量吸氧、无创和有创机械通气、俯卧位通气等措施。严格落实疑难危重症患者会诊制度、死亡病例讨论制度等医疗质量安全核心制度，强化对治愈出院患者健康监测，确保重症患者救治质量。开展康复者恢复期血浆采集和临床治疗工作，建立应急储备库，截至5月31日，全国共采集恢复期血浆2765人次，1689人次患者接受恢复期血浆治疗，取得较好治疗效果。

Pooling premium resources to treat severe cases.The sudden appearance of Covid-19 in Wuhan put an overwhelming strain on its medical resources. There was a severe shortage of hospital beds in the early stage as the number of infections surged. By directing resources to Wuhan, China expanded the capacity of designated hospitals to deal with severe cases and increased the number of beds. Patients in severe and critical condition were gathered for treatment and intensive care at the best hospitals with the greatest capacity for accommodating patients with infectious respiratory diseases. Two hospitals with 1,000-plus beds each – Huoshenshan and Leishenshan – were built as specialist hospitals for treating infectious diseases, and a number of designated and general hospitals were expanded or remodeled. The number of beds for severe cases quickly increased from around 1,000 to more than 9,100. Hospitals were able to admit large numbers of patients who were seriously ill.

The treatment strategy for severe cases was improved, and tailored treatment provided to individual patients. Inspection teams consisting of top experts were organized to regularly inspect Wuhan’s designated hospitals and evaluate patients in critical condition and their therapeutic regimen. For those with serious underlying medical conditions, who accounted for more than 80 percent of all severe cases, case-by-case treatment was prescribed after consultation with a multidisciplinary team consisting of experts on infection, respiratory diseases, heart and kidney diseases, and intensive care. In addition, a set of standards were formulated for nursing patients in severe and critical condition, and such measures as high-flow nasal cannula oxygen therapy, non-invasive and invasive mechanical ventilation, and ventilation in a prone position were adopted. Expert consultation on complex, severe and critical cases, and fatal cases, and other core medical security systems were strictly implemented. Those who have been cured and discharged from hospital have received rigorous health monitoring, and patients in severe condition have been given quality medical treatment.

The plasma of convalescent Covid-19 patients has been collected to set up an emergency plasma reserve, and convalescent plasma therapy has been applied in clinical treatment. As of May 31, convalescent plasma had been collected from 2,765 recovered patients, and 1,689 patients had been treated with the therapy, with positive results.